Pathophysiologic consequences following inhibition of a CFTR-dependent developmental cascade in the lung

J Craig Cohen1, Janet E Larson

  • 1Louisiana State University Health Sciences Center, Department of Medicine, School of Medicine, New Orleans, LA 70112, USA. ccohen@lsuhsc.edu

BMC Developmental Biology
|February 8, 2005
PubMed
Abstract

Insights

Transient in utero gene knockout in rats revealed the cystic fibrosis transmembrane conductance regulator (CFTR) gene

Area of Science:

  • Developmental biology
  • Genetics
  • Respiratory medicine

Background:

  • Studying late gestation developmental genes is challenging due to early lethality and compensatory mechanisms.
  • The role of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in cystic fibrosis (CF) pathophysiology is difficult to assess.
  • Transient in utero knockout (TIUKO) technology offers a novel approach to overcome these limitations.

Purpose of the Study:

  • To investigate the developmental role of the CFTR gene in the rat lung using TIUKO technology.
  • To model aspects of the human cystic fibrosis phenotype in utero.

Main Methods:

  • Utilized transient in utero knockout (TIUKO) technology in rat fetuses.
  • Administered antisense cftr to transiently disrupt CFTR gene function during development.

Main Results:

  • Rat fetuses treated with antisense cftr exhibited pathologies mirroring human CF.
  • Developed lung fibrosis, chronic inflammation, and reactive airway disease.
  • Expressed the CF Antigen (MRP8/14), a recognized marker for CF in human patients.

Conclusions:

  • TIUKO technology is effective for evaluating genes with early lethality or compensatory phenotypes.
  • CFTR is crucial for normal secretory cell differentiation in lung development.
  • CFTR absence leads to a constitutive inflammatory process contributing to CF pathophysiology.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.